-
Discovery of K V 1.3 ion channel inhibitors [Elektronski vir] : medicinal chemistry approaches and challengesGubič, Špela ...The KV1.3 voltage gated potassium ion channel is involved in many physiological processes both at the plasma membrane and in the mitochondria, chiefly in the immune and nervous systems. Therapeutic ... targeting KV1.3 with specific peptides and small molecule inhibitors shows great potential for treating cancers and autoimmune diseases, such as multiple sclerosis, type I diabetes mellitus, psoriasis, contact dermatitis, rheumatoid arthritis, and myasthenia gravis. However, no KV1.3 targeted compounds have been approved for therapeutic use to date. This review focuses on the presentation of approaches for discovering new KV1.3 peptide and small-molecule inhibitors, and strategies to improve the selectivity of active compounds toward KV1.3. Selectivity of dalatazide (ShK-186), a synthetic derivate of the sea anemone toxin ShK, was achieved by chemical modification and has successfully reached clinical trials as a potential therapeutic for treating autoimmune diseases. Other peptides and small-molecule inhibitors are critically evaluated for their lead-like characteristics and potential for progression into clinical development. Some small-molecule inhibitors with well defined structure-activity relationships have been optimized for selective delivery to mitochondria, and these offer therapeutic potential for the treatment of cancers. This overview of KV1.3 inhibitors and methodologies is designed to provide a good starting point for drug discovery to identify novel effective KV1.3 modulators against this target in the future.Source: Medicinal research reviews. - ISSN 1098-1128 (41, iss. 4, 2021, str. 2423-2473)Type of material - e-articlePublish date - 2021Language - englishCOBISS.SI-ID - 61605123
Author
Gubič, Špela |
Hendrickx, Louise Antonia |
Toplak, Žan |
Sterle, Maša |
Peigneur, Steve |
Tomašič, Tihomir |
Pardo A., Luis |
Tytgat, Jan |
Zega, Anamarija |
Peterlin-Mašič, Lucija
Topics
Farmacevtska kemija |
KV1.3 channel |
design of KV1.3 inhibitors |
mitochondrial KV1.3 |
peptide inhibitors |
small-molecule inhibitors
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|---|
Gubič, Špela | 53671 |
Hendrickx, Louise Antonia | |
Toplak, Žan | 52375 |
Sterle, Maša | 53583 |
Peigneur, Steve | |
Tomašič, Tihomir | 28334 |
Pardo A., Luis | |
Tytgat, Jan | |
Zega, Anamarija | 18633 |
Peterlin-Mašič, Lucija | 19317 |
Select pickup location:
Material pickup by post
Notification
Subject headings in COBISS General List of Subject Headings
Select pickup location
Pickup location | Material status | Reservation |
---|
Please wait a moment.